All In Biotech

Free tool

FAERS Monitor: Tigecycline

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 211158 or its brand name (Tigecycline, Tigecycline). Reports on generic versions are filed under their own applications.

Reports

4,358

Serious

4,073

93% of reports

Hospitalization

1,833

Death reported

1,192

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective638
  • off label use549
  • nausea302
  • drug resistance213
  • sepsis207
  • vomiting205
  • septic shock193
  • thrombocytopenia193
  • pathogen resistance172
  • product use in unapproved indication168
  • diarrhoea156
  • acute kidney injury153
  • condition aggravated153
  • death147
  • treatment failure139

Reports by year received

View as table
YearReports
20052
20068
200731
200863
200950
201037
201161
201271
201380
201479
2015151
2016107
2017216
2018241
2019404
2020360
2021419
2022332
2023417
2024518
2025413
2026298

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,801 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pathogen resistanceSignal17292.880.015,242
drug resistanceSignal21340.335.48,076
septic shockSignal19321.518.73,743
sepsisSignal2079.07.91,463
thrombocytopeniaSignal1938.37.31,244
treatment failureSignal1398.16.9861
acute kidney injurySignal1534.84.1464
product use in unapproved indicationSignal1683.32.8266
off label useSignal5493.02.8775
condition aggravatedSignal1532.42.1129
drug ineffectiveSignal6382.32.2519
vomitingSignal2052.11.8120
nausea3021.81.7120
diarrhoea1561.21.04
death1470.80.76

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.